Article
How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms?
Cellular and molecular life sciences : CMLS - 1 Jul 2007
Edouard T, Montagner A, Dance M, Conte F, Yart A, Parfait B, Tauber M, Salles J P, Raynal P
Abstract excerpt
Activating and inactivating mutations of SHP-2 are responsible, respectively, for the Noonan (NS) and the LEOPARD (LS) syndromes. Clinically, these developmental disorders overlap greatly, resulting in the apparent paradox of similar diseases caused by mutations that oppositely influence SHP-2 phosphatase activity. While the mechanisms remain unclear, recent functional analysis of SHP-2, along with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
